The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Everything you need to know about the decision on who should be screened for prostate cancer ...

PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 cases and less progress in mortality, even as other experts disagree and cite ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant prostate cancer have many effective treatment options, but questions remain ...

It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.

The UK National Screening Committee (UK NSC) has rejected calls for population-wide prostate cancer screening using the PSA ...

Atlanta Falcons Legends join Emory Healthcare to raise awareness for prostate and lung cancer screening. Early detection can ...